Buprenorphine is not the same as Suboxone, but it is the main active ingredient in Suboxone. The key difference: Suboxone contains buprenorphine combined with a second ingredient called naloxone, while buprenorphine can also be prescribed on its own. This distinction matters because the two are used in slightly different situations, and understanding which one you’re taking (or being offered) helps you know what to expect.
What Buprenorphine Actually Is
Buprenorphine is a partial opioid agonist, meaning it activates the same receptors in your brain that other opioids do, but only partially. It reduces cravings and withdrawal symptoms without producing the intense high of full opioids like heroin or oxycodone. Because it has a ceiling effect, taking more beyond a certain dose doesn’t increase its effects, which makes it significantly harder to misuse than full opioids.
Buprenorphine is the active ingredient in several brand-name medications. Some contain only buprenorphine (like Subutex), while others combine it with naloxone (like Suboxone, Zubsolv, and Bunavail). It’s also used in pain management patches and as a monthly injectable called Sublocade, which delivers steady levels of the drug from a single injection under the skin of the abdomen.
What Makes Suboxone Different
Suboxone is a specific brand-name product that pairs buprenorphine with naloxone. Naloxone is an opioid blocker, the same drug used in Narcan to reverse overdoses. Its role in Suboxone is a built-in safeguard against misuse.
Here’s how that works: when you take Suboxone as directed, dissolving the film or tablet under your tongue, the naloxone is barely absorbed into your bloodstream. It has very poor bioavailability through the mouth, so it essentially does nothing. The buprenorphine does all the therapeutic work. But if someone tried to dissolve the tablet and inject it, the naloxone would become fully active intravenously and block the opioid effects, triggering withdrawal symptoms. This design discourages diversion, where prescribed medication gets sold or shared for injection use.
Suboxone is FDA-approved specifically for the treatment of opioid dependence as part of a broader plan that includes counseling and psychosocial support. It is not approved or appropriate for pain management.
When Buprenorphine Alone Is Preferred
In most cases, the combination product (buprenorphine plus naloxone) is the standard choice for treating opioid use disorder. But there are situations where buprenorphine without naloxone is the better option.
Pregnancy is the most common one. The CDC, the American College of Obstetricians and Gynecologists, and SAMHSA all recommend buprenorphine (or methadone) as first-line treatment for pregnant people with opioid use disorder. The preference for the monotherapy product during pregnancy is based on having a longer safety record for the single ingredient in that population.
Buprenorphine alone may also be used during the initial induction phase of treatment, before a patient transitions to a combination product. And some patients who have documented sensitivities or reactions to naloxone may stay on buprenorphine-only products long term.
Available Forms
The variety of buprenorphine products can be confusing, so here’s how they break down:
- Suboxone: Buprenorphine plus naloxone, available as a dissolving film placed under the tongue.
- Zubsolv and Bunavail: Also buprenorphine plus naloxone, in sublingual tablet and buccal (cheek) film forms respectively.
- Subutex: Buprenorphine only, as a sublingual tablet. Largely replaced by generics.
- Sublocade: A monthly buprenorphine injection given under the skin. Patients need to be stable on sublingual buprenorphine before switching to this form.
- Buprenorphine patches: Used for chronic pain rather than opioid use disorder, delivering low doses through the skin.
All sublingual and buccal forms must fully dissolve in the mouth to be absorbed. If swallowed, buprenorphine will not work.
Side Effects to Know About
Because buprenorphine is the active ingredient in both products, the side effect profiles are very similar. The most common effects include headache, nausea, vomiting, constipation, increased sweating, and insomnia. These tend to be most noticeable in the first days to weeks of treatment and often improve as your body adjusts.
One side effect that gets less attention is dental damage. The FDA has flagged this as a concern for all buprenorphine products that dissolve in the mouth, whether they contain naloxone or not. Reports include tooth decay, cavities, oral infections, and tooth loss, even in patients with no prior dental problems. Out of 305 reported cases, the most common outcome was tooth extraction. If you’re taking any dissolving form of buprenorphine, rinsing your mouth with water after the medication fully dissolves and waiting at least an hour before brushing can help protect your teeth.
The naloxone in Suboxone does not typically cause additional side effects when the medication is taken as directed, since so little of it reaches the bloodstream through the mouth.
Why the Names Get Confused
Much of the confusion comes from the fact that “buprenorphine” is used loosely to refer to an entire class of medications. A doctor might say “I’m going to prescribe buprenorphine” and mean Suboxone, because buprenorphine is the drug doing the work. In casual conversation and even in some clinical settings, the terms get used interchangeably. But they are distinct prescriptions with different formulations, and knowing which one you’re actually taking matters for understanding your treatment, especially if you become pregnant or need to switch forms.
If you’re unsure which product you’ve been prescribed, checking the label for “buprenorphine/naloxone” versus “buprenorphine” alone will tell you immediately whether you’re on a combination or monotherapy product.